Observational Study on the Treatment of Trigeminal Neuralgia by Radiosurgery
NATURE
1 other identifier
observational
150
1 country
1
Brief Summary
This study aims to evaluate the outcome of patient treated by radiosurgery on LINAC with high dose rate for classical trigeminal neuralgia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2021
CompletedFirst Submitted
Initial submission to the registry
December 15, 2022
CompletedFirst Posted
Study publicly available on registry
January 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2036
February 19, 2025
February 1, 2025
5 years
December 15, 2022
February 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain relief
Barrow Neurological Institute pain intensity scale - score I to V - V is the worst Barrow Neurological Institute (BNI) pain intensity scale Barrow Neurological Institute (BNI) pain intensity scale
24 months
Secondary Outcomes (2)
Toxicity of radiosurgery
1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years
Variation of quality of life
1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years
Eligibility Criteria
all patients with trigeminal neuralgia treated by radiosurgery on LINAC
You may qualify if:
- Classical trigeminal neuralgia according the International Classification of Headache Disorders
- Trigeminal neuralgia resistant to the maximum tolerated medical therapy, with pain intensity according to the Barrow Neurological Institute (BNI) score IV or V.
- Patients aged \> 18
You may not qualify if:
- Patients suffering from secondary Trigeminal neuralgia (tumour in the cerebellopontine angle, arteriovenous malformation or multiple sclerosis)
- Previous history of radiosurgery procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Princesse Grace
Monaco, 98000, Monaco
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2022
First Posted
January 10, 2023
Study Start
December 15, 2021
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2036
Last Updated
February 19, 2025
Record last verified: 2025-02